T0	Participants 60 74	duodenal ulcer
T1	Participants 180 409	283 patients with active duodenal ulcer to compare possible factors that may affect healing and relapse in patients treated with a potent antisecretory agent, cimetidine, or a site-protective and cytoprotective agent, sucralfate.
T2	Participants 1059 1070	both groups
T3	Participants 1170 1215	patients with healed ulcers, 238 participated
T4	Participants 1426 1434	patients